SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-19-008205
Filing Date
2019-04-30
Accepted
2019-04-30 06:20:20
Documents
5
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A acrx20190429_10ka.htm 10-K/A 1114107
2 EXHIBIT 31.3 ex_142244.htm EX-31.3 4024
3 EXHIBIT 31.4 ex_142245.htm EX-31.4 3666
4 a1.jpg GRAPHIC 18269
5 a2.jpg GRAPHIC 18760
  Complete submission text file 0001437749-19-008205.txt   1173980
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35068 | Film No.: 19778281
SIC: 2834 Pharmaceutical Preparations